Pharmacophore an International Research Journal
Pharmacophore
Submit Manuscript
Open Access | Published: 2019 - Issue 6

The Experience of Using Drug Mirtazapine in Comprehensive Therapy of Idiopathic Cystitis in Cats Download PDF


Olga A. Vorontsova, Tatyana I.Shutova, Nikolay A. Pudovkin, Tatyana M.Prokhorova, Petr V. Smutnev, Ivan G. Subbotin
Abstract

The article presents the results of research on the experience of using drug Mirtazapine in combination therapy of idiopathic cystitis in cats. It has been found that the use of Mirtazapine for cats with idiopathic cystitis at the dosage of 1.88 mg per day for two weeks improves the overall state and cognitive functions. The drug has a pronounced analgesic effect. Mirtazapine does not cause changes in the hematological parameters of cats. In addition, injection of Mirtazapine reduces the pH value of urine after 14 days by 6.7 %, after 30 days — by 10.7 %, and after 60 days — by 10.3 %, compared to the first day. A decrease of 3.5 % (30 days) and 7.6% (60 days) of pH was also noted in animals in the second group. All of these allow concluding the reasonability of using Mirtazapine for cats with idiopathic cystitis.

QR code:

Short Link:
Quick Access

Associations

Pharmacophore
ISSN: 2229-5402

Copyright © 2024 Pharmacophore. Authors retain copyright of their article if they are accepted for publication.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.